How new biomolecular platforms and digital technologies are changing R&D

More from: | McKinsey | 0 By going digital, biotech pioneers with promising biomolecular platforms are improving drug discovery and development—and changing the pharmaceutical industry. The use of digital technologies is transforming business as usual in industries ranging from aviation to retail to telecommunications. But other sectors—including the pharmaceutical industry—have... Read more